Oxidative Degradation in Biopharmaceuticals: Risks and Mitigation
Oxidative Degradation in Biopharmaceuticals: Risks and Mitigation Managing Oxidative Degradation in Biopharmaceuticals: Risks and Mitigation Strategies Oxidative degradation is a prevalent and critical degradation pathway affecting the stability, efficacy, and safety of biopharmaceuticals. Proteins and peptides, due to their structural complexity and reactive amino acids, are particularly vulnerable to oxidation. Factors such as exposure to…
Read More “Oxidative Degradation in Biopharmaceuticals: Risks and Mitigation” »